Overview

Noetic Psychedelic
Fund LP

A venture fund launched by Grey House Partners GP Inc. to invest in emerging and early-stage psychedelic-based wellness, therapeutic and pharmaceutical companies around the globe.

Portfolio

The Noetic Psychedelic Fund LP focuses on finding teams with the skills, expertise, management
experience, and governance structures in place to build.

Eleusis

Eleusis is dedicated to unlocking the potential of serotonin 2A receptor agonists, commonly referred to as psychedelics, by mitigating and managing psychoactivity.

PsyBio Therapeutics

PsyBio Therapeutics is developing biosynthetic psychoactive compounds which offer a new paradigm of treatment to reverse the course of mental health issues.

Tactogen

Tactogen is developing the next generation of empathogen medicines, gentler compounds within MDMA family for at-home use that can increase feelings of openness.

Noetic Psychedelic Fund LP

no•et•ic

“From the Greek noēsis/ noētikos meaning inner wisdom, direct knowing, or subjective understanding”

Noetic science refers to a multidisciplinary field that brings objective scientific tools and techniques together with subjective understanding to study the full range of human experience.

Our Mission

Our mission is to nurture the scientific advancement of mental, emotional, psychological and physical health by investing in alternative therapies, modalities, and sciences that are committed to optimizing our human experience.

Our Commitment

We are committed to the development of pure, innovative and sustainable products and services that utilize technological innovation and the power of bioavailable plants that are often psychedelic in nature to help define a healthy future for our people and our planet.

Our Focus

Psychedelic and non-psychedelic sustainable solutions for depression and anxiety.

Our Team

6 years in venture capital, Silicon Valley, with focus on technology and software

20 years in mid-market M&A / Private Equity – c suite – private/publics – with top decile returns of 10x to 40x

BA in Economics from Queen’s University, Kingston

MBA from Trinity College, Dublin

Michael Franks

Grey House Partners Managing Partner

9 years at RBC Capital Markets in real estate banking, corporate credit, and derivative sales & trading

9 years at DGAM (acquired by The Carlyle Group) – Head of Marketing and Client Services, helped build AUM to $6.8B at peak.

BA in Economics and Political Science from Columbia University

M. Sa’ad Shah

Grey House Partners Managing Partner

6 years leading VC- and PE-backed growth businesses: SVP Sales at Top Hat (10X growth in 4 years) and CEO at Globalfaces Direct (100% growth in 2 years)

6 years as a consulting leader with McKinsey & Company, including a fellowship to McKinsey’s Social Sector Office

MBA from Harvard Business School

Naseem Saloojee

Grey House Partners Venture Partner

Subscribe

Subscribe to keep in touch and learn about the latest developments in the emerging psychedelic medicine space